Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of PF-00345439 (Remoxy) Formulations in Healthy Volunteers
NCT02059915Phase 1Completed
- Sponsor
- Cassava Sciences
- Start
- Apr 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of oxycodone in pain (4 arms), sponsored by Cassava Sciences. Primary endpoints: Area Under the Curve From Time Zero to Extrapolated Infinite Time and Maximum Observed Plasma Concentration. Started Apr 2014; status: completed.
02
Drugs
oxycodone
03
Conditions
pain
Beyond the preview
Go deeper on NCT02059915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02059915.